Neonatal Cardiac Physiology/Pathophysiology/Pulmonary Hypertension
Neonatal Cardiac Physiology/Pathophysiology/ Pulmonary Hypertension 3
Mohan Pammi, MD, PhD, MRCPCH (he/him/his)
Professor
Baylor College of Medicine
Bellaire, Texas, United States
Accurate prognostication of mortality and need for ECMO in infants with Congenital Diaphragmatic Hernia (CDH) can inform clinical management, transfer to an ECMO center and parent counselling.
Objective:
To determine the prognostic value of echocardiographic markers for mortality and need for ECMO in infants with CDH without other major congenital anomalies.
Design/Methods:
We performed the systematic review according to PRISMA guidelines
DATA SOURCES: We searched the electronic databases Ovid-MEDLINE, Embase, Scopus, CINAHL, the Cochrane library and conference proceedings up to July 2022.
STUDY SELECTION: Studies evaluating the prognostic performance of echocardiographic parameters in the diagnosis and management of CDH in term and preterm infants.
DATA EXTRACTION AND SYNTHESIS: Risk of bias and applicability were assessed using QUIPS tool. We used a random effects model for meta-analysis to compute mean differences (MD) for continuous outcomes and relative risk (RR) for binary outcomes with 95% confidence intervals (CI).
MAIN OUTCOMES AND MEASURES: Our primary outcome was mortality and secondary outcomes were need for ECMO, duration of ventilation, length of stay and need for oxygen and/or inhaled nitric oxide.
Results: Twenty-six observational studies were included, and the methodological quality was adequate except for 2 studies. Meta-analysis of the 2-3 studies reporting adequate information, the diameters right pulmonary artery at birth (mm) [MD 0.95 (95% CI 0.45, 1.46)], diameter of left pulmonary artery at birth (mm) [MD 0.79 (0.58, 0.99), left ventricular dysfunction [ RR 2.40 (1.98, 2.91)], right ventricular dysfunction [RR 1.83 (1.29, 2.60)] and severe pulmonary hypertension [RR1.69 (1.53, 1.86)] were useful in prognosticating survival, whereas L/R pulmonary artery ratio [MD -0.03 (-0.19, 0.12)], heart rate (beats per minute) [MD 0.44 (-13.21, 14.10)], systolic duration (seconds) [MD -0.01 (-0.03, 0.01)] and diastolic duration (seconds) [MD -0.00 (-0.07, 0.07)] were not useful. Left ventricular dysfunction [ RR 3.30 (2.19, 4.98)] and right ventricular dysfunction [RR 2.16 (1.85, 2.52)] were useful in prognosticating the need for ECMO.
Conclusion(s):
Left and right ventricular dysfunction, pulmonary hypertension and pulmonary artery diameter are useful prognostic factors among CHD patients. There is a need for consensus on optimal selection and timing of echocardiographic parameters for prognostication, which should be evaluated in large, well-designed trials.